Literature DB >> 404857

Phosphopyridoxal complexes with histamine and histidine. (5) The kinetics of cyclic compound formation between histamine and pyridoxal-5'-phosphate in the presence of pig kidney diamine oxidase and rat intestinal histaminase.

K Sasiak, D Kierska, C Maśliński.   

Abstract

Pig kidney diamine oxidase (DAO) and rat intestinal histaminase (Hi-ase) activities are inhibited in vitro by high concentrations of both a substrate (histamine) and a coenzyme (pyridoxal-5'-phosphate). This inhibition may be at least partially associated with the formation of a cyclic compound between histamine (Hi) and pyridoxal-5'-phosphate (PLP). The dynamics of this cyclic compound formation in the presence of both enzymes has been examined. In an incubation mixture containing partially purified pig kidney DAO, the rate of cyclization decreased slightly as compared with a buffer. On the contrary, in the presence of crude rat intestinal histaminase, the rate of cyclization was inhibited significantly; this inhibition was proportional to the amount of enzyme preparation present in the incubation mixture. The possible mechanism of the influence of enzyme protein on the rate of cyclic compound formation, and its possible biological significance, are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 404857     DOI: 10.1007/bf01964876

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  20 in total

1.  Phosphopyridoxal complexes with histamine and histidine. (4) The kinetics of complex formation between histidine and pyridoxal 5' -phosphate in the presence of bacterial histidine decarboxylase.

Authors:  D Kierska; C Maśliński
Journal:  Agents Actions       Date:  1975-12

2.  Pyridoxylamines.

Authors:  D HEYL; E LUZ
Journal:  J Am Chem Soc       Date:  1948-04       Impact factor: 15.419

3.  Phosphopyridoxal complexes with histamine and histidine. (3) The influence of presumed complex on activity of rat intestinal histaminase.

Authors:  K Sasiak; D Kierska; M Boguslawski; C Maśliński
Journal:  Agents Actions       Date:  1975-02

4.  Inhibition of tyrosine transaminase activity by norepinephrine.

Authors:  I B Black; J Axelrod
Journal:  J Biol Chem       Date:  1969-11-25       Impact factor: 5.157

5.  The reaction of amines with pyridoxal azomethines. The question of transaldimation and its role in the mechanism of vitamin B6 enzymes.

Authors:  E H Abbott; A E Martell
Journal:  J Am Chem Soc       Date:  1971-11       Impact factor: 15.419

6.  Pyridoxine and pyridoxal analogs. 13. A nuclear magnetic resonance study of the condensation of polyfunctional amino acids with pyridoxal.

Authors:  E H Abbott; A E Martell
Journal:  J Am Chem Soc       Date:  1970-03-25       Impact factor: 15.419

7.  Inactivation of tetrameric rabbit muscle pyruvate kinase by specific binding of 2 to 4 moles of pyridoxal 5'-phosphate.

Authors:  G S Johnson; W C Deal
Journal:  J Biol Chem       Date:  1970-01-25       Impact factor: 5.157

8.  An interaction between S-adenosyl-L-methionine and pyridoxal 5'-phosphate, and its effect on Saccharomyces cerevisiae.

Authors:  R W Trewyn; K D Nakamura; M L O'Connor; L W Parks
Journal:  Biochim Biophys Acta       Date:  1973-12-19

9.  A new histaminase assay.

Authors:  H G Roscoe; D Kupfer
Journal:  Anal Biochem       Date:  1972-06       Impact factor: 3.365

10.  Plasma diamine oxidase activity after single or chronic administrations of histamine.

Authors:  J M Krajewska; C Maslinski
Journal:  Eur J Pharmacol       Date:  1969-09       Impact factor: 4.432

View more
  3 in total

1.  Phosphopyridoxal cyclic compounds with histamine and histidine. 6: The formation of phosphopyridoxal cyclic compounds with histamine and histidine in the presence of biological material.

Authors:  D Kierska; K Sasiak; C Maśliński
Journal:  Agents Actions       Date:  1978-10

2.  In vivo formation of histamine phosphopyridoxal cyclic compounds.

Authors:  D Kierska; K Sasiak; C Maśliński
Journal:  Agents Actions       Date:  1981-04

3.  Vegetal diamine oxidase alleviates histamine-induced contraction of colonic muscles.

Authors:  Armelle Tchoumi Neree; Rodolphe Soret; Lucia Marcocci; Paola Pietrangeli; Nicolas Pilon; Mircea Alexandru Mateescu
Journal:  Sci Rep       Date:  2020-12-09       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.